Troluce Capital Advisors LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Troluce Capital Advisors LLC disclosed 18 US equity positions worth $196.4m in its Q2 2025 13F filing. The largest position was FLR at 33.9% of the reported book, followed by COF and KVUE. Against the Q1 2025 filing, it opened 12 new positions, added to 1 and reduced 5 among the top 18 holdings.
What did Troluce Capital Advisors LLC own in Q2 2025? Top 18 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | FLR FLUOR CORP NEW | Industrials | 33.9% | $66.7m | 1,300,000 | – | new |
| 2 | COF CAPITAL ONE FINL CORP | Financial Services | 18.3% | $36.0m | 169,400 | – | new |
| 3 | KVUE KENVUE INC | Consumer Defensive | 10.1% | $19.9m | 950,000 | – | new |
| 4 | WDC WESTERN DIGITAL CORP | Technology | 8.3% | $16.3m | 255,150 | -64% | reduced |
| 5 | MIR MIRION TECHNOLOGIES INC | Industrials | 6.6% | $12.9m | 600,000 | – | new |
| 6 | AMCOR PLC | 6.3% | $12.4m | 1,350,000 | -36% | reduced | |
| 7 | AMRZ AMRIZE LTD | Basic Materials | 5.3% | $10.4m | 210,000 | – | new |
| 8 | ASND ASCENDIS PHARMA A/S | Healthcare | 2.6% | $5.2m | 30,000 | – | new |
| 9 | HUDSON PAC PPTYS INC | 1.9% | $3.7m | 1,350,000 | – | new | |
| 10 | MERUS N V | 1.9% | $3.7m | 70,000 | – | new | |
| 11 | ROIV ROIVANT SCIENCES LTD | Healthcare | 1.4% | $2.8m | 250,000 | -65% | reduced |
| 12 | SGRY SURGERY PARTNERS INC | Healthcare | 1.1% | $2.2m | 100,000 | – | new |
| 13 | GHRS GH RESEARCH PLC | 0.5% | $1.0m | 85,791 | -45% | reduced | |
| 14 | VSTS VESTIS CORPORATION | Industrials | 0.5% | $1.0m | 179,105 | – | new |
| 15 | BTBT BIT DIGITAL INC | 0.4% | $766.5k | 350,000 | – | new | |
| 16 | DHC DIVERSIFIED HEALTHCARE TR | 0.4% | $716.0k | 200,000 | – | new | |
| 17 | CORZ CORE SCIENTIFIC INC NEW | Technology | 0.2% | $426.8k | 25,000 | -99% | reduced |
| 18 | TCRX TSCAN THERAPEUTICS INC | 0.1% | $217.5k | 150,000 | 79% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.